MedPath

Development and Validation of a Predictive Score for Surgical Site Infections

Not Applicable
Completed
Conditions
Partial or Total Gastrectomy
Colon or Colorectal Resection
Hepatectomy
Pancreaticoduodenectomy
Interventions
Biological: Peripheral venous blood samples
Registration Number
NCT05523713
Lead Sponsor
Hopital Foch
Brief Summary

More than 8 millions surgical interventions are carried out each year in France. Postoperative complications, in particular infectious, can occur in 10 to 60% of cases and are the cause of postoperative revision in 30% of cases, an increase in mortality, length of stay, readmissions and lead to significant additional socio-economic costs. Currently, improvements in surgical practices have not reduced the incidence of surgical site complications. In this context, the development of predictive scores for the risk of post-operative complication becomes urgent in order to implement new interventions (pre-habilitation) or to modify surgical decisions (timing, approach) in order to reduce the risk of complications before surgery. Several recent studies highlights the importance of the immune response in postoperative prognosis. In particular, an imbalance between the adaptive and innate response involving MDSCs has been demonstrated in patients with postoperative complications.Thanks to new techniques for analyzing the immune system, in-depth analysis of the immune system before surgery is a very promising approach aimed at identifying predictive biomarkers of postoperative prognosis.

Our team has developed and patented a multivariate model integrating mass cytometry data, proteomics and clinical data collected before surgery to accurately predict the occurrence of a surgical site complication (AUC = 0.94, p\<10e-7) in a monocentric cohort of 43 patients to major abdominal surgery (Stanford University).

The objective of the present study is to generalize and validate this preoperative predictive score of infectious complications of the surgical site in the 30 days following major digestive surgery on a larger workforce within a multicenter cohort and to validate this score at using a machine learning method.

Detailed Description

Research hypothesis and expected impact:

Postoperative complications are frequent and associated with excess mortality and increased costs for the health system. But, it is possible to avoid a significant number of these complications through prehabilitation programs, in particular to prepare patients at risk, and to reduce these postoperative events by 30%. However, it is currently not possible to predict, before surgery, which patients are at risk of developing a complication. Current predictive clinical scores such as the one developed by the American College of Surgeons are unsatisfactory (AUC = 68%).

This study will be a reference study to define the groups of patients at risk of complications in order to develop, in a second step, personalized patient pathways in order to optimize their health before surgery and thus improve post-operative results.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
283
Inclusion Criteria

Patients will be included:

  • Aged 18 and over
  • Having undergone elective major digestive surgery:

Major surgery defined according to the recent recommendations of the European Surgical Association - PMID: 32172309 by a rate of infectious or cognitive complications between 20 and 30% according to the ACS risk calculator

  • Having expressed their non-opposition to participate in the study
  • Being affiliated to a French health insurance
Exclusion Criteria

Patients with the following criteria will not be included:

  • Aged under 18
  • Having an ASA 4 or more, in palliative care
  • Having an expected duration of hospitalization < 24 hours
  • Not speaking French, illiterate patient
  • Having expressed their opposition to participate in the study
  • Current pregnancy or breastfeeding
  • Absence of affiliation to social security plan
  • Being deprived of liberty or under guardianship

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients with major elective digestive surgeryPeripheral venous blood samplesThe size of the cohort is 240 patients Population: Patients with major elective digestive surgery (eg, colon or colorectal resection, partial or total gastrectomy, pancreaticoduodenectomy, hepatectomy).
Patients with major elective digestive surgeryPeripheral venous blood samplesThe size of the cohort is 300 patients Population: Patients with major elective digestive surgery (eg, colon or colorectal resection, partial or total gastrectomy, pancreaticoduodenectomy, hepatectomy).
Primary Outcome Measures
NameTimeMethod
Performance of the preoperative prediction score for infectious complications of the surgical site.30 days

Defined as superficial or deep surgical site infection and organ as defined by CDC 2021.

The performance of the score will be evaluate based on the F1 score criterion and the AUROC.

F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Secondary Outcome Measures
NameTimeMethod
Performance of the postoperative prediction score for infectious complications of the surgical site.30 days

Defined as superficial or deep surgical site infection and organ as defined by CDC 2021.

The performance of the score will be evaluate based on the F1 score criterion and the AUROC.

F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the preoperative prediction score for lung infections30 days

Defined by the prescription of antibiotics with one or more of the following elements: new or altered sputum, new or altered lung opacities on chest X-ray, fever \> 38°C, leukocytes \>12 × 109 /L.

The performance of the score will be evaluate based on the F1 score criterion and the AUROC.

F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the preoperative prediction score for urinary tract infections30 days

As defined by CDC 2021.

The performance of the score will be evaluate based on the F1 score criterion and the AUROC.

F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the pre- and post-operative prediction score for the risk of post-operative septic shock30 days

Defined according to Sepsis-3 criteria: Sepsis-related Organ Failure Assessment score ≥ 2, persistent hypotension requiring vasopressors to maintain mean arterial pressure ≥ 65 mmHg and serum lactate \> 2 mmol/L despite adequate volume resuscitation.

The performance of the score will be evaluate based on the evaluation of the F1 score criterion and the AUROC. F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: Score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the pre- and post-operative prediction score for postoperative cardiovascular complications30 days

Defined as arrhythmia, cardiac arrest, acute coronary syndrome and acute heart failure.

The performance of the score will be evaluate based on the evaluation of the F1 score criterion and the AUROC. F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: Score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the pre- and post-operative prediction score for the risk of postoperative deep vein thrombosis or pulmonary embolism.30 days

Confirmed by imaging (angioscanner for pulmonary embolism and echo-doppler for deep vein thrombosis).

The performance of the score will be evaluate based on the evaluation of the F1 score criterion and the AUROC. F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: Score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the pre- and post-operative prediction score for the risk of post-operative acute renal failure.30 days

Defined by an increase of creatinine \> 1.5 times of the baseline value or diuresis \< 0.5 ml/kg/h for 6 to 12 hours.

The performance of the score will be evaluate based on the evaluation of the F1 score criterion and the AUROC. F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: Score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the pre- and post-operative prediction score for the risk of acute bleeding, hematoma or postoperative anemia30 days

Requiring surgical intervention or blood transfusion.

The performance of the score will be evaluate based on the evaluation of the F1 score criterion and the AUROC. F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: Score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the pre- and post-operative prediction score for the risk of postoperative occlusion or ileus.30 days

Defined as failure to resume transit within 72 hours of surgery.

The performance of the score will be evaluate based on the evaluation of the F1 score criterion and the AUROC. F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: Score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the pre- and post-operative prediction score for the risk of postoperative delirium30 days

Defined as disturbed attention and disturbed consciousness, with cognitive impairment not explained by a pre-existing neurological pathology.

The performance of the score will be evaluate based on the evaluation of the F1 score criterion and the AUROC. F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: Score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Performance of the pre- and post-operative prediction score for the overall severity of postoperative complications.30 days

Based on the Comprehensive Complication Index (CCI), with a severity threshold at CCI ≥ 20.

The performance of the score will be evaluate based on the evaluation of the F1 score criterion and the AUROC. F1: score ranges from 0 to 1, where 0 is the worst and 1 is the best possible score.

AUROC: Score ranges from 0.5 to 1 where 1 is the best score and 0.5 means the model is as good as random.

Intra-hospital mortality30 days

Assessed from patient medical records

Length of hospital stay30 days

Assessed from patient medical records

Cost of stay30 days

From Groupe Homogène de Séjours ( GHS) collected in the medical information departments (DIM) based on the Programme de médicalisation des systèmes d'information (PMSI) of each establishment.

Score results30 days

The score is calculated using a machine learning method integrating immune, plasma protein and clinical data. The aim is to validate and generalize the score result (AUC = 0,94, p\<10e-7) of a multivariate model already developed in a monocentric cohort of 43 patients undergoing major abdominal surgery (Stanford University).

Trial Locations

Locations (4)

La pitiè Salpâtrière Hospital

🇫🇷

Paris, France

Saint Antoine Hospital

🇫🇷

Paris, France

Saint Joseph Hospital

🇫🇷

Paris, France

FOCH Hospital

🇫🇷

Suresnes, France

© Copyright 2025. All Rights Reserved by MedPath